<DOC>
	<DOC>NCT00595543</DOC>
	<brief_summary>To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.</brief_summary>
	<brief_title>Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<criteria>Patients must be diagnosed with acute pseudophakic CME within 12 months of cataract surgery Males and females 18 years and older Able to provide written informed consent Complicated cataract surgery, particularly posterior capsule rupture and vitreous loss PreExisting macular pathology, including macular edema, macular scar, macular hole, or macular pucker History of Uveitis Ipsilateral intraocular surgery prior to cataract surgery CME greater than one year duration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>